Efficacy and safety of therapies for COVID-19 in pregnancy: a systematic review and meta-analysis

BACKGROUND: Clinical evidence suggests that pregnant women are more vulnerable to COVID-19, since they are at increased risk for disease progression and for obstetric complications, such as premature labor, miscarriage, preeclampsia, cesarean delivery, fetal growth restriction and perinatal death. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Gennaro, Francesco, Guido, Giacomo, Frallonardo, Luisa, Segala, Francesco Vladimiro, De Nola, Rosalba, Damiani, Gianluca Raffaello, De Vita, Elda, Totaro, Valentina, Barbagallo, Mario, Nicastri, Emanuele, Vimercati, Antonella, Cicinelli, Ettore, Liuzzi, Giuseppina, Veronese, Nicola, Saracino, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634005/
https://www.ncbi.nlm.nih.gov/pubmed/37946100
http://dx.doi.org/10.1186/s12879-023-08747-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634005/
https://www.ncbi.nlm.nih.gov/pubmed/37946100
http://dx.doi.org/10.1186/s12879-023-08747-2

Ejemplares similares